semaj83/ctmatch_classification huggingface dataset:
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Elective Cranial Procedures With Dural Incision Pre-Operative Subject is scheduled for an elective cranial procedure involving a dural incision using any of the following surgical locations/approaches (or combination): frontal, temporal, occipital, and parietal (i.e. supratentorial), and/or midline or lateral suboccipital (i.e. infratentorial.) Subject requires a procedure involving a Class 1/clean wound (uninfected surgical wound in which no inflammation is encountered) Intra-Operative Subject's linear extent of durotomy is ≥2 cm Subject's dural margins from the edges of bony defect are ≥3 mm throughout Subject's CSF leak is present intra-operatively following completion of primary dural closure (with or without non-autologous duraplasty or autologous tissue), either spontaneously or upon Valsalva maneuver, at up to 20 cm H2O for up to five (5) seconds  Subject requires a procedure involving a translabyrinthine, transsphenoidal, transoral approach, or any procedure that penetrates the air sinus or mastoid air cells. Note: Superficial penetration of mastoid air cells is not an if cells are appropriately sealed (e.g. bone wax) Subject has a CSF shunt such as; ventriculo-peritoneal, ventriculo-pleural, ventriculo-atrial or lumbo-peritoneal shunts Subject has an external ventricular or lumbar CSF drain that must be left in place after surgery Subject has had radiation treatment to the surgical site, or standard fractionated radiation therapy is planned within ten days post index-procedure. (Note: stereotactic radiosurgery prior to the planned index procedure is not an criterion) Subject has a systemic infection or evidence of any infection near planned operative site. Intra-Operative Subject has an Incidental finding that meets any pre-operative criterion listed above Subject requires the intra-operative placement of a CSF diversion device (e.g. ventricular catheter, subdural catheter, lumbar drain, or other device designed to externally evacuate CSF) that will be left in place after the procedure. Note: Subgaleal drains used for acute post-operative management of the incision site are permitted
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.5-2.917,  Influenza All Subjects Healthy children 6-35 months of age (naïve cohort) or 12-35 months of age (fully primed cohort) Free of obvious health problems as established by medical history and clinical examination before entering the study Parent/legal guardian willing and capable of signing written informed consent Parent/legal guardian expected to be available for entire study Parent/legal guardian can be reached by telephone Fully Primed Cohort -Have received two doses of 2009-2010 H1N1 and two doses of trivalent inactivated influenza vaccine (TIV) at anytime in the past as defined for the purpose of this study  All Subjects Have known allergy to eggs or other components of the vaccine. *Refer to the Fluzone package insert for a list of vaccine components Known or suspected latex allergy Former premature infants (<32 weeks) History of bronchodilator use more than 2 times per week within 28 days of vaccination Significant underlying chronic illness (e.g., congenital heart disease, bronchopulmonary dysplasia) Immunodeficiency disease or use of immunosuppressive therapy by the participant, including perinatal exposure to or infection with human immunodeficiency virus (HIV), or known infection with hepatitis B or hepatitis C Any other condition that, in the clinical judgment of the investigator, may interfere with vaccine evaluation. Children receiving antibiotics are eligible for enrollment Have long term use of glucocorticoids including oral, parenteral or high-dose inhaled steroids (>800 mcg/day of beclomethasone dipropionate or equivalent) within the preceding 6 months. (Nasal and topical steroids are allowed.) Previous, exposure to an investigational drug or investigational vaccine within 28 days prior to vaccination in this trial
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-40.0,  Influenza Subject must have a BMI >18.5 and ≤ 28.5 kg/m2 Subject must have no clinically significant abnormal findings, as judged by the Investigator, on the physical examination, ECG, medical history or clinical laboratory results during screening Subject must be a non-user of tobacco products, or smoke ≤ 10 cigarettes per day (minimum 6 months prior to first dose) Subject must have a negative urine screen for drugs of abuse and a negative alcohol breath test at screening and check-in Subject must refrain from consuming alcohol for 72 hours prior to each dose Subject must be able to communicate well with the Investigator, to understand and comply with the requirements of the study, and be judged suitable for the study in the opinion of the Investigator Subject must give voluntary written informed consent to participate in this trial  Subject must not have previous influenza vaccination within the 12 months prior to test drug vaccination Subject must not have had an influenza like illness within the 3 months prior to test drug vaccination Subject must not have a history or presence of significant neurological, cardiovascular, pulmonary (including asthma), hepatic, metabolic, rheumatic, autoimmune, haematological or renal disorder Subject must not have an oral temperature >38°C on day of vaccination (otherwise subject maybe be re-assigned to a subsequent cohort) Subject must not suffer from an inherited or acquired immunodeficiency Subject must not suffer from a disease or be undergoing treatment that can affect immune response such as systemic or high dose inhaled corticosteroids (>800µg/day beclometasone or equivalent), radiation treatment, cytotoxic drugs or non-steroidal anti-inflammatory drugs Subject must not have a serologically positive test for human immunodeficiency virus (HIV), hepatitis B surface antigen (HBsAg) or hepatitis C virus (HCV) Subject must not have a history of severe allergic reactions and/or anaphylaxis Subject must not have any arm rash or tattoos which could confound the interpretation of any injection site reactions Subject must not have participated in a previous clinical trial within 90 days prior to the first vaccination
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Immunity to Influenza Vaccine healthy aged 65+ years  <65 years influenza vaccine allergy Guillain-Barre weight <110 pounds
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 1.0-3.0,  Child Development children aged one to three years of chronological age, of both genders, enrolled full-time, ie more than six hours in childcare elected for search  children with minor changes or deviations in child development, who did at least one major meal (lunch or dinner) in the nursery, or other educational institution attended, in addition
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Healthy Volunteers Influenza NIH employees scheduled to receive the Influenza and H1N1 vaccines through OMS. 2. Health status confirmed by History, Physical Exam and blood work through the CHI Screening Protocol. 3. Age 18 years and older (no upper limit). 4. Able to comprehend the investigational nature of the protocol and provide informed consent  Recipient of another vaccine or immune modulating drug within 6 months prior to study entry. 2. Severe allergies to eggs or their products. 3. Prior severe reactions to vaccines. 4. Participation on any blood collection or blood donation procedure during study participation. 5. Current pregnancy (women of child bearing potential must have a negative serum pregnancy test done on screening within 1 week of protocol accrual)
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.5-999.0,  H1N1 Virus Participants of the clinical service evaluation of novel H1N1v vaccine First or second blood sample for the clinical service evaluation successfully collected  Withdrawn from clinical service evaluation of novel H1N1v vaccine Second blood sample for the clinical service evaluation not collected
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.75-50.0,  Vaccination Parents of child >9 months to 25 months Child with at least one visit to one of the participating clinical sites in the previous 12 months Parental cell phone number recorded in the registration system
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Healthy Completed a medical screening questionnaire English speaking No allergies to the drugs Able to complete the forms If a woman of childbearing age, agree to use contraception  History of substance abuse, psychiatric disorder, acquired brain injury, the possibility of pregnancy (not using birth control, and of child bearing age) Use of any medication that would contraindicate benzodiazepine administration Pregnant or nursing
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Seasonal Influenza seasonal influenza vaccine indications according to the CDC employees of partner corporations executing study  none
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 50.0-75.0,  Colorectal Cancer Screening Adults aged 50-75 at the time of their flu shots who are also due for colorectal cancer screening  none -
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 50.0-75.0,  Colorectal Cancer Participants must be primary care patients one of 6 participating clinics 2. Participants must be aged 50-75 3. Participants must have received a flu shot during a primary care visit on any date during the 2009-10 flu shot season (beginning September 28, 2009 and ending at the end of January, 2010)  None
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.5-999.0,  Hematopoietic Stem Cell Transplant Hematologic Malignancy Patient Population HSCT recipients who are greater than 60 days post transplant Age 6 months and older who are greater than 60 days post post allogeneic hematopoietic cell transplant Show neutrophil recovery, platelet count > 50,000/mm3 (may be transfused), no known disease relapse No history of previous allergic reaction to influenza vaccine, known egg allergy or Guillan-Barre Syndrome No flu vaccine in previous 4 months, no Campath in previous 6 months, no intravenous immune globulin (IVIG) in previous 3 months Controls Age 18 to 50 years No history of previous allergic reaction to influenza vaccine, known egg allergy or Guillan-Barre Syndrome No flu vaccine in previous 4 months
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza Subject is 18 years of age or older on the day of inclusion Informed consent form (ICF) has been signed and dated Able to attend all scheduled visits and to comply with all trial procedures For a woman of childbearing potential, use of an effective method of contraception or abstinence from at least 4 weeks prior to the first vaccination until at least 4 weeks post-vaccination  Known pregnancy, or a positive urine pregnancy test Currently breastfeeding a child History of serious adverse reaction to any influenza vaccine Receipt of any vaccine in the 4 weeks preceding the trial vaccination Planned receipt of any vaccine between Visit 1 and Visit 2 Participation in another interventional clinical trial investigating a vaccine, drug, medical device, or medical procedure in the 4 weeks preceding the first study vaccination or during the course of the study Receipt of any influenza vaccine since 01 August 2010 (including 2009 H1N1 monovalent vaccine) Known systemic hypersensitivity to any of the vaccine components, or history of a life-threatening reaction to the vaccine(s) used in the trial or to a vaccine containing any of the same substances Receipt of blood or blood-derived products in the past 3 months, which might interfere with assessment of the immune response Thrombocytopenia, bleeding disorder, or receipt of anticoagulants contraindicating intramuscular vaccination
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Cow's Milk Allergy Proved cow"s milk allergy  Pregnant women
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Migraine Age 18 years or older Have had migraines for at least 3 years Have between 4 and 15 migraines a month Able to speak and read the English language  Women who are pregnant or nursing, or planning on becoming pregnant in the next 10 months Individuals who have a had a heart attack, stroke, peripheral artery disease, atherosclerotic aortic disease, carotid artery disease, or diabetes individuals at high risk for cardiovascular disease
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Influenza General good health determined by a screening evaluation ≤120 days prior to IMP administration and on the day of admittance to quarantine Using methods of contraception, (e.g. spermicidal gel plus condom) for the entire duration of the study, up to the Study Completion visit, and refrain from fathering a child in the three months following study drug administration Negative HIV, hepatitis B and C antibody screens Negative class A drugs, alcohol and nicotine screen Seronegative (≤10 HAI) for challenge virus Have not been vaccinated for influenza virus since 2006 (as determined in the medical history) or had a known influenza-like illness in the current season, defined as in the last 12 months  Presence of any significant acute or chronic, uncontrolled medical or psychiatric illness, including but not exclusive to the conditions listed in Appendix 2, that in the view of the Investigator is associated with increased risk of complications of respiratory viral illness Abnormal pulmonary function as evidenced by clinically significant abnormalities in spirometry Presence of household member or close contact who is: less than 3 years of age; known immunodeficient; receiving immunosuppressants; undergoing/soon to undergo chemotherapy; diagnosed with emphysema or COPD; is elderly residing in a nursing home; severe lung disease or medical condition; received a transplant (bone marrow or solid organ) History of asthma, COPD, pulmonary hypertension, reactive airway disease, or any chronic lung condition of any aetiology Any laboratory test or ECG which is abnormal and deemed by the investigator to be clinically significant Venous access inadequate for phlebotomy demands Regular daily smokers during the 6 months prior to study entry or those who have a significant history of any tobacco use at any time Subject is diabetic History or evidence of autoimmune disease or known impaired immune responsiveness Recent and/or recurrent history of autonomic dysfunction